Barrington Research Comments on Option Care Health, Inc.’s Q1 2025 Earnings (NASDAQ:OPCH)

Option Care Health, Inc. (NASDAQ:OPCH) – Research analysts at Barrington Research lifted their Q1 2025 earnings per share (EPS) estimates for Option Care Health in a research report issued on Wednesday, April 24th. Barrington Research analyst M. Petusky now forecasts that the company will earn $0.30 per share for the quarter, up from their previous forecast of $0.26. Barrington Research currently has a “Outperform” rating and a $38.00 target price on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.13 per share. Barrington Research also issued estimates for Option Care Health’s Q4 2025 earnings at $0.37 EPS and FY2026 earnings at $1.55 EPS.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating analysts’ consensus estimates of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The firm had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the business earned $0.21 EPS. The business’s revenue for the quarter was up 12.8% on a year-over-year basis.

Separately, Jefferies Financial Group increased their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a report on Monday, March 4th.

Option Care Health Stock Down 2.1 %

OPCH stock opened at $29.29 on Thursday. Option Care Health has a 1-year low of $24.23 and a 1-year high of $35.74. The stock has a market cap of $5.09 billion, a price-to-earnings ratio of 19.27, a price-to-earnings-growth ratio of 1.74 and a beta of 1.22. The company has a current ratio of 1.77, a quick ratio of 1.33 and a debt-to-equity ratio of 0.74. The company’s 50 day moving average is $32.04 and its 200 day moving average is $31.50.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the stock in a transaction on Monday, February 26th. The stock was acquired at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the purchase, the director now directly owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPCH. Principal Securities Inc. purchased a new position in shares of Option Care Health in the fourth quarter valued at about $27,000. Parallel Advisors LLC raised its position in Option Care Health by 130.2% during the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock valued at $28,000 after purchasing an additional 478 shares during the last quarter. TFO Wealth Partners LLC lifted its holdings in Option Care Health by 24,625.0% in the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after buying an additional 985 shares during the period. First Horizon Advisors Inc. purchased a new stake in Option Care Health in the 3rd quarter worth approximately $37,000. Finally, Park Place Capital Corp grew its position in shares of Option Care Health by 48.4% in the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock worth $38,000 after buying an additional 372 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.